LBX Pharmacy Chain Joint Stock Company (SHA:603883)

China · Delayed Price · Currency is CNY

13.04

+0.15 (1.16%)

Sep 30, 2026, 3:00 PM CST

Market Cap	9.90B -21.0%
Revenue (ttm)	22.46B +1.2%
Net Income	430.77M +4.0%
EPS	0.57 +4.7%
Shares Out	758.89M
PE Ratio	23.00
Forward PE	17.53
Dividend	0.41 (3.14%)
Ex-Dividend Date	Sep 10, 2026

Volume	6,210,215
Open	12.86
Previous Close	12.89
Day's Range	12.86 - 13.08
52-Week Range	10.67 - 17.96
Beta	0.42
Analysts	Buy
Price Target	18.14 (+39.11%)
Earnings Date	Oct 27, 2026

About SHA:603883

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The company is also involved in wholesale and retail of pharmaceutical products; Chinese medicine research and development; e-commerce; food and departmen... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 2001

Employees 36,892

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603883

Full Company Profile

Financial Performance

In 2025, SHA:603883's revenue was 22.24 billion, a decrease of -0.54% compared to the previous year's 22.36 billion. Earnings were 381.85 million, a decrease of -26.44%.

Financial Statements

Analyst Summary

According to 13 analysts, the average rating for 603883 stock is "Buy." The 12-month stock price target is ¥18.14, which is an increase of 39.11% from the latest price.

Price Target

¥18.14

(39.11% upside)

Analyst Consensus: Buy

Stock Forecasts